Cardiac myosin binding protein C (cMyBP-C) is a phosphorylation-dependent force regulator and plays an important role in controlling myosin and actin dynamic interaction. Point-mutations of cMyBP-C that interfere with cMyBP-C threonine/serine phosphorylation resulted in hypertrophic cardiomyopathy and cardiac failure. However, it remains largely unknown how cMyBP-C tyrosine phosphorylation is regulated during cardiac hypertrophy and heart failure. Integrins are receptors of extracellular matrix and are the sensors of cardiac mechanical stretch. Focal adhesion kinase (FAK) plays an essential role in integrin-initiated signal transduction and regulates multiple cellular functions in various types of cells including cardiomyocytes. To identify the regulatory mechanism of cMyBP-C tyrosine phosphorylation during cardiac hypertrophy, we examined the effect of FAK on phosphorylation of cMyBP-C. Immunoprecipitation analysis showed that FAK and cMyBP-C are associated within the intact mouse heart.
Introduction
Cardiac contraction and relaxation rely on actin and myosin cross-bridge cycling, and deregulated cross-bridge cycling impairs cardiac pump functions (1, 2) . Cardiac myosin binding protein C3 (cMyBP-C) is a myosin-associated protein and plays an important role in regulating cardiac contraction and relaxation through affecting kinetic interactions between myosin and actin (3) . Dephosphorylated cMyBP-C prefer binds to myosin and inhibits the interaction between myosin and actin (4) (5) (6) (7) . Consistently, the overall phosphorylation levels of cMyBP-C in the heart are decreased in heart failure and cardiomyopathy patients (8) (9) (10) . In mammalian cells, phosphorylation usually occurs on serine, threonine and tyrosine residues. The importance of serine/threonine phosphorylation of cMyBP-C has been well documented and more than five serine/threonine phosphorylation sites have been identified (11) . Recently, newly available information indicates that tyrosine phosphorylation of cMyBP-C may also be involved in cardiomyopathy formation. Mass spectrometry (MS) analysis documented that Tyr79 of cMyBP-C can be phosphorylated (12) . Moreover, the Tyr237Ser mutant was reported in hypertrophic cardiomyopathy patients (13) . Unlike the important effect of serine/ threonine phosphorylation of cMyBP-C on cardiac function, it remains unclear the physiological functions of cMyBP-C tyrosine phosphorylation during cardiomyopathy formation.
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase and is critical mediator in integrin-initiated signal transduction (14, 15) . FAK contains a centrally located catalytic tyrosine kinase domain and large non-catalytic N-and C-terminal domains (14, 16, 17) . Once FAK get activated, the FAK FERM domain, which is located at the N-terminus of FAK, moves away from the kinase domain and induces FAK to switch from an inactive state to an active state (18) (19) (20) . Tyr397 is the binding site of Src SH2 domain and numerous FAK functions rely on FAK and Src to form a complex (14) .
In addition, FAK has three proline-rich domains that are important for FAK binding to endophalin A2 and other effector proteins (21) .
FAK regulates multiple cellular functions in various types of cells including cardiomyocytes (16, 17) . FAK is expressed in both neonatal and adult cardiomyocytes and plays an essential role in regulating embryonic heart development and heart hypertrophy (22) (23) (24) . FAK is distributed in the multiple subcellular structures of the cardiomyocyte, including the costamere, Z disk and sarcomere (A band) (17). A substantial fraction of FAK is associated with myosin in the sarcomeres under the nonstimulated condition (17). In response to mechanical stress, FAK relocates to the Z-disks and costameres (25) . Pulsatile stretch induces rapid FAK activation and FAK phosphorylation is paralleled to the extent and duration of mechanical stimulation, indicating that FAK is involved in mechanical stretch-initiated signal transduction in the cardiomyocytes (26, 27) . Once activated, FAK binds to Src through the phosphorylated Tyr397. The FAK/Src complex results in the phosphorylation of Tyr576 and Tyr577 that locate in the FAK kinase domain. Moreover, Src can phosphorylate FAK C-terminal Tyr861 and Tyr925 and create binding sites for other proteins containing SH2 domains. It was also documented that a sustained pressure overload on in vitro rat heart induced tyrosine phosphorylation of FAK, as well as enhanced association of FAK with Src and Grb2 (28) . We and others have reported that FAK is involved in cardiac hypertrophy formation in response to pressure overload (22, 29, 30) . cMyBP-C is an important regulator for myosin and actin cross-bridge cycling and the effect of FAK on cMyBP-C phosphorylation remains enigmatic. In this manuscript, we examined the effect of regulatory mechanisms of FAK on cMyBP-C phosphorylation in cultured cells and pressure overloaded mouse heart.
Results

Mechanical stress increased cMyBP-C tyrosine phosphorylation.
To determine the effect of pressure overload on cMyBP-C tyrosine phosphorylation, we performed transvers aorta constriction (TAC) or sham surgery on 3month-old 129/SvJ wild type mice. After 1 hour of TAC surgery, the proximal aorta pressure gradient of the ligation site increased approximately tenfold, compared to the distal ligated aorta ( Fig. 1A) . Four weeks later, the heart and body weight ratio in the TAC group increased twofold, compared to the sham group ( Fig. 1B) . To detect the phosphorylation status of cMyBP-C in intact sarcomeres, we isolated myofibers from TAC and sham mice hearts 1 hour later following the surgery. After running an SDS-PAGE, we blotted the membrane with PY100 antibodies that recognize the phosphorylated tyrosine residues. The membrane was then re-probed with cMyBP-C antibodies as a loading control. Our data showed that a pressure overload in the heart significantly increased the level of cMyBP-C tyrosine phosphorylation (around 40%) ( Fig. 1C ), indicating that cMyBP-C tyrosine phosphorylation may be involved in cardiac hypertrophy in response to pressure overload.
FAK and cMyBP-C are associated in the intact heart
It is well documented that integrin-mediated signal transduction plays an essential role in pressure overload-induced cardiac hypertrophy (31, 32) . FAK is one of the most important tyrosine kinases in integrin-initiated signal transduction, so it is possible that TAC induced cMyBP-C phosphorylation is mediated by FAK. To investigate the potential regulatory mechanisms of cMyBP-C phosphorylation by FAK, we first examined the interaction between FAK and cMyBP-C in the mouse heart. Tissue lysates were prepared from 3-month-old adult mouse cardiac ventricles and then precipitated with FAK antibodies. In parallel, we incubated the tissue lysates with the same amount of control IgG. The Western blot results using cMyBP-C antibody showed that cMyBP-C was associated with FAK, and the normal IgG barely precipitated cMyBP-C ( Fig. 2A) .
To avoid the possibility that the association between FAK and cMyBP-C is through other sarcomere proteins, we overexpressed Myc-tagged cMyBP-C with/without human influenza hemagglutinin (HA)-tagged FAK in Ad 293 cells. The Western blot results showed that the overexpressed cMyBP-C can be detected by the Myc antibody An immunoprecipitation experiment presented that cMyBP-C was associated with FAK, but not with the pKH3 vector alone ( Fig. 2B , right panel). In line with this result, a reciprocal immunoprecipitation experiment showed that FAK was found in anti-Myc immunoprecipitates (Fig. 2C, line 4 ), but could not be detected in the precipitates by the control normal IgG (Fig. 2C , line 1). Taken together, these results demonstrated that FAK and cMyBP-C are associated in the heart and that this association is not mediated by other sarcomere proteins. were followed by western blotting with anti-cMyBP-C antibodies. Consistent with our previous result ( Fig. 2B ), cMyBP-C was coprecipitated with the full-length FAK. FAK N-terminus did not associate with cMyBP-C, but the FAK kinase domain was strongly associated with cMyBP-C. Interestingly, we found that the association between FAK mutant (Δ 1-125) and cMyBP-C was increased as compared to the full-length FAK.
FAK kinase domain is required for FAK and cMyBP-C interaction
Similar expression levels of cMyBP-C were verified by blotting of whole cell lysates with anti-cMyBP-C antibodies (Fig. 3B , bottom panel). All these data indicate that the FAK kinase domain is the major binding site for FAK and cMyBP-C association.
As an important signal transduction regulator, FAK binds to different downstream effectors and then regulates various cellular functions. To investigate the potential cMyBP-C binding sites in FAK, Ad 293 cells were cotransfected with cMyBP-C containing different FAK point mutations. Whole cell lysates were precipitated with HA antibodies and followed by western blotting with cMyBP-C antibodies. Our results showed that FAK Tyr397 and kinase activity were required for the associations between cMyBP-C and FAK. However, the FAK Pro878/881Ala mutant and the FAK Pro715/718Ala mutant did not affect the association between FAK and cMyBP-C ( Fig.   3C ).
cMyBP-C association with FAK through multiple domains
To determine the regions of cMyBP-C necessary for association with FAK, we created a series of cMyBP-C truncation mutations as shown in Fig. 4A . The Myc tagged cMyBP-C mutants and the full-length of FAK were cotransfected into Ad 293 cells.
Three days later, whole cell lysates were precipitated with Myc antibodies and then blotted with FAK antibodies. Our results showed that the full-length cMyBP-C was associated with FAK and that the association of cMyBP-C fragment 4 (F4) with FAK was significantly increased. In addition, we detected that cMyBP-C F5 and F1 fragments were also associated with FAK, indicating that cMyBP-C could associate with FAK through multiple domains ( Fig. 4B ). 
FAK-mediated Src phosphorylation on cMyBP-C
FAK kinase activity is required for cMyBP-C phosphorylation
Previous data showed that FAK and Src Tyr527Phe forming a complex and inducing cMyBP-C phosphorylation. In addition, FAK kinase activity is required for FAK interacting with cMyBP-C. To determine the importance of FAK kinase activity for cMyBP-C phosphorylation, we overexpressed cMyBP-C, Src Tyr527Phe with wild type FAK or FAK kinase dead mutant. In line with previous data, overexpression of wild type FAK or FAK kinase dead mutant alone cannot phosphorylate cMyBP-C. Src Tyr527Phe can weakly phosphorylate cMyBP-C. Overexpression of FAK kinase dead protein and Src Tyr527Phe induced cMyBP-C phosphorylation. Moreover, the phosphorylation level of cMyBP-C was significantly increased when wild type FAK and Src Tyr527Phe were coexpressed with cMyBP-C ( Fig. 6A ).
Because the FAK kinase domain is required for the association between cMyBP-C and FAK, we next examined the effect of cMyBP-C on FAK activity. FAK or the pKH3 vector alone was cotransfected with cMyBP-C and followed by western blot using PY100 antibodies. We found that overexpression of cMyBP-C, instead of the pKH3 vector alone, decreased a 120 kD fragments phosphorylation, indicating that the overexpression of cMyBP-C inhibited FAK phosphorylation (Fig. 6B ).
FAK and Src phosphorylated cMyBP-C in vitro
To further determine the role of FAK and Src on cMyBP-C phosphorylation, we overexpressed FAK, Src and FAK plus Src in Ad 293 cells. Immunoprecipitation experiments were then performed using anti-HA antibodies. The purified cMyBP-C was incubated with FAK, Src or the FAK plus Src complex for two hours and then separated by SDS-PAGE. Western blotting results showed that both FAK and Src can phosphorylate cMyBP-C, but the FAK and Src complex did not further enhance cMyBP-C phosphorylation in vitro ( Fig. 7) .
Discussion
Sarcomere is the contraction unit of cardiomyocyte and its contraction and relaxation functions depend on the dynamic interactions between myosin and actin, which is regulated by cMyBP-C (33) . Previous studies have documented that protein kinase A (PKA)-mediated cMyBP-C serine phosphorylation is essential for sarcomere contraction and relaxation (34) . However, the regulatory mechanisms of cMyBP-C tyrosine phosphorylation in response to mechanical stretch in the heart remain unclear. In the current manuscript, we have demonstrated that pressure overload enhances cMyBP-C tyrosine phosphorylation in the mice hearts. In addition, we found that the Src/FAK complex phosphorylates cMyBP-C and that the FAK kinase domain is needed for FAK and cMyBP-C association. Moreover, FAK kinase activity is required for the association between FAK and cMyBP-C. We also found that cMyBP-C has multiple domains that bind to FAK and the association between FAK and cMyBP-C inhibited FAK phosphorylation.
Integrin-FAK mediated signal transduction plays an important role in cardiac development and cardiac hypertrophy (22, 23) . Previously, we have reported that the inactivation of FAK in cardiomyocytes enhanced TAC-induced cardiac hypertrophy (22) . FAK Tyr397 locates at the junction of The FAK N-terminus and the kinase domain and is the binding site for Src and PI3K, etc. (16) . Our results showed that the FAK Tyr397Phe mutant disrupted the association between FAK and cMyBP-C. It is possible that cMyBP-C competes with Src and directly binds to FAK Tyr397. This competition may interfere with the association between FAK and Src and decrease FAK phosphorylation. In line with this result, we found that overexpression of cMyBP-C inhibits FAK phosphorylation.
Another possibility is that cMyBP-C does not bind to FAK Y397 directly but can only bind to the active FAK kinase domain. In the inactivated stage, the FAK kinase domain was covered by FAK N-terminus. The FAK Tyr397Phe mutant causes FAK to lose its interaction with Src, which resulted in its inability to be fully phosphorylated and expose to the centrally located FAK kinase domain. In this case, cMyBP-C cannot access the FAK kinase domain, which then inhibits FAK and cMyBP-C association.
The cMyBP-C-F4 fragment strongly associates with FAK and its association is even stronger than that of full-length cMyBP-C, suggesting that the C0-C1 fragment inhibits cMyBP-C form association with FAK. We also noted that the association between C5-C10 is much weaker than that of the M-C10 fragment, indicating that M-C4 is required for FAK and cMyBP-C association. Intriguingly, we found C0-C4 fragments do not associate with FAK. A possible explanation is that the C0-C1 fragment inhibits the association between FAK and cMyBP-C.
In response to shear stretch stimulation, FAK relocates to the costermere and Zdisks in cardiomyocyte (35) . The Franchini group reported that Myosin binds to the FAK N-terminus and inhibits FAK phosphorylation (36) . In another word, the association of Myosin and FAK inhibits FAK activity. Our data shows that cMyBP-C binds to the FAK kinase domain and the FAK/Src complex can then phosphorylate cMyBP-C. Based on this available information, we speculate that pressure overload stimulates FAK to move to the costamere and to form a complex with Src. The Src/FAK complex causes FAK Nterminus move away from its kinase domain. Subsequently, the exposed kinase domain binds to cMyBP-C and stimulates cMyBP-C phosphorylation. The phosphorylated cMyBP-C may change its structure, accelerate myosin and actin interaction and promote cardiac contraction and relaxation. After FAK is dephosphorylated by phosphatases or inhibited by cMyBP-C directly, FAK disassociates from cMyBP-C and then binds to myosin. The interaction between myosin and FAK enhances FAK N-terminus to interact with its kinase domain and then inhibits FAK phosphorylation.
In conclusion, we have demonstrated that FAK can associate with cMyBP-C and that this association is required for the Src/FAK complex to phosphorylate cMyBP-C.
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Legend.
Immunoprecipitation and Western blotting
Immunoprecipitation and Western blotting experiments were performed as described previously (37, 38) . Ad 293 cells were cultured in 6-well plates with DMEM containing 10% fetal bovine serum. Plasmids were transfected into the cells with Lipofectamine 2000 following the manufacture's instruction. Subconfluent cells or mouse hearts were lysed with modified RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 1 mM sodium vanadate, 10 mM sodium pyrophosphate, 10 mM NaF, 1% Triton X-100, 0.5% SDS, 0.1% EDTA, 10 μg/ml leupepetin, 10 μg/ml aprotinin and 1 mM PMSF). Immunoprecipitation was carried out by incubating lysates with various antibodies and protein A beads at 4 °C for overnight.
The beads were boiled with loading buffer and resolved by SDS-PAGE.
Immunoprecipitation and Western blotting were performed using the following antibodies, rabbit polyclonal FAK antibody (Cell Signaling), HA tag antibody (HA-7, Sigma-Aldrich), Myc tag antibody (A7, Abcam; 4A6 Millipore).
Generation of plasmids with different cMyBP-C fragments.
Myc-tagged cMyBP-C full length and truncated fragments were generated by PCR using the following primers: gag gat cca atg ccg gag cca ggg aag aaa cc and gtg aat tca ctg agg aac tcg cac ctc cag (cMyBP-C full-length); gag gat cca atg ccg gag cca ggg aag aaa cc and gtg aat tca gac agt gag gtt gaa gtt aca gc (cMyBP-C-F1); gag gat cca atg ccg gag cca ggg aag aaa cc and gtg aat tca gtc aat ctt gac ctc cat gaa gtg (cMyBP-C-F2); gag gat cca atg ccg gag cca ggg aag aaa cc and gtg aat tca tgg gac atc gat gac ctt gac tg (cMyBP-C-F3); gag gat cct atg cat gag gcc att ggt tct gga gac and gtg aat tca ctg agg aac tcg cac ctc cag (cMyBP-C-F4); gag gat cca atg ttt gtg cct agg cag gaa cct ccc and gtg aat tca ctg agg aac tcg cac ctc cag (cMyBP-C-F5). PCR products were digested with BamH I and EcoR I and then inserted into pCDNA3-Myc vectors.
Myofibril and cytosolic fraction Preparation
Hearts were homogenized using a motor-driven homogenizer in 2 ml of ice-cold K60 buffer (60 mM KCL, 20 mM MOPS at pH7.4 and 2 mM MgCl2) with protease inhibitor (Sigma P8340, 1:100 dilution), 10 uM phosphatase inhibitor (Sigma) and 1mM EDTA. The homogenate was then centrifuged at 1000g for 5 minutes at 4°C. After incubation the supernatant with 1% Triton-X 100 for 30 minutes on ice, the whole tissue lysates were centrifuged again at 1000g for 10 minutes at 4°C. The supernatant was transferred to a clean Eppendorf tube and kept as cytosolic fraction. The pellet was washed twice with K60 buffer containing protease inhibitor and re-suspended in K60 with 1ug/ul of BSA. The concentration of protein was evaluated with Piece® BCA Protein Assay Kit.
Statistical analysis
Data are presented as mean ± standard deviation. Means were compared by analysis of variance between groups (ANOVA). P≤0.05 was considered statistically significant. 
